/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / EXORPHIA

EXORPHIA

Japan

EXORPHIA is a biotechnology company that develops and engineers extracellular vesicles for use in assisted reproductive technology and pharmaceutical applications

Healthcare & Biotech

EXORPHIA, based in Japan, has 2 investors on file, among them Coral Capital and Keio Innovation Initiative. Its site was last checked 7 Nov 2026: site answers.

exorphia.com

Investors

2 investors on file
InvestorEvidenceType
Coral CapitalPortfolio pageVenture capital
Keio Innovation InitiativePortfolio pageVenture capital

More from Coral Capital

91 companies on its checked portfolio

Its portfolio leans to AI & Machine Learning (16%), Healthcare & Biotech (15%), Enterprise Software (12%).

Albert InventAlbert Invent develops an AI operating system for chemistry research a…DioseveDioseve develops reproductive cell technology to address challenges in…G.U.Group, Inc.G.U.Group, Inc. provides blockchain infrastructure and web3 products.Generation Lab Health TechGeneration Lab offers a biological age test and provides personalized …GenomelinkGenomelink allows users to upload their DNA test results to access var…

See Coral Capital's full profile · Who invests alongside it

More from Keio Innovation Initiative

42 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (36%), AI & Machine Learning (17%), Industrial & Manufacturing (14%).

AdipoSeedsAdipoSeeds develops a technology to cultivate blood platelets from fat…CureAppCureApp develops medical treatment apps based on medical evidence to s…HeartseedHeartseed Inc. develops and delivers cardiac regenerative medicine to …Kringle PharmaKringle Pharma is a late-stage regenerative medicine bioventure that c…LIFESCAPESThe company uses brain science and AI to support rehabilitation for pa…

See Keio Innovation Initiative's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get EXORPHIA and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Coral Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/exorphia.com/investors

# also
GET /v1/companies/exorphia.com
GET /v1/companies/exorphia.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing